. . . . . . . . "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." . . . "NeuroDKG" . . . "Adults" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "CqKUmQjVJIy7d4BKbZtNI2P7RJ7WipUH00kRQn8Q0lNXYQqs56FJ3/IWYh5nohxla5/gp0KS6QX8jEvLukT9cZOjCOGfhDF8o4CSBp+Ov7WicgIVnEB9zyVtUg8li9kZFmn0juBKtZ7P/4V9MBsitvpX7IPCCB3W4UO83JAA588=" . . "2021-03-22T10:56:37.839+01:00"^^ . . . . .